Showing results (191-200 of 234) with videos related to
Sort By:
Pageof 24
Gut|July 31, 2021
Discovery and 3D imaging of a novel ΔNp63-expressing basal cell type in human pancreatic ducts with implications in diseaseSandrina Martens, Katarina Coolens, Mathias Van Bulck, et al.Journal for Immunotherapy of Cancer|March 26, 2022
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumorsRocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín, et al.Cell Reports. Medicine|January 21, 2026
Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancersJulian Frädrich, Carmen Mota Reyes, Michel Hendel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E M van Kessel, Kirstin A van der Keur, Lars Dyrskjøt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2018
CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 StatusCarolina Rubio, Mónica Martínez-Fernández, Cristina Segovia, et al.European Urology|September 11, 2013
Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcomeYves Allory, Willemien Beukers, Ana Sagrera, et al.Plos One|November 12, 2014
PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma casesEsperanza Martín-Sánchez, Lina Odqvist, Socorro M Rodríguez-Pinilla, et al.European Urology|September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder CancerAurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.Nature Genetics|October 15, 2013
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidyCristina Balbás-Martínez, Ana Sagrera, Enrique Carrillo-de-Santa-Pau, et al.European Urology|June 7, 2017
Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation StudyLars Dyrskjøt, Thomas Reinert, Ferran Algaba, et al.Pageof 24